Arformoterol Tartrate Inhalation Solution 15 ug/2mL
Arformoterol Tartrate Inhalation Solution · SOLUTION · Ritedose Pharmaceuticals, LLC
Arformoterol Tartrate Inhalation Solution is a solution containing arformoterol tartrate inhalation solution at 15 ug/2mL, taken respiratory (inhalation). Manufactured by Ritedose Pharmaceuticals, LLC.
Key Facts
- Brand Name
- Arformoterol Tartrate Inhalation Solution
- Generic Name
- Arformoterol Tartrate Inhalation Solution
- NDC Code (Product)
76204-026- Manufacturer
- Ritedose Pharmaceuticals, LLC
- Strength
- 15 ug/2mL
- Dosage Form
- SOLUTION
- Route
- RESPIRATORY (INHALATION)
- Marketing Status
- Application #
- ANDA214736
- Marketing Start
- 02/27/2023
Recall History
No Recall HistoryFrequently Asked Questions
What is Arformoterol Tartrate Inhalation Solution used for?
Arformoterol Tartrate Inhalation Solution contains Arformoterol Tartrate Inhalation Solution. It is a solution taken respiratory (inhalation). Consult your doctor for specific uses.
Is Arformoterol Tartrate Inhalation Solution a controlled substance?
Arformoterol Tartrate Inhalation Solution is not classified as a controlled substance by the DEA.
What is the generic name for Arformoterol Tartrate Inhalation Solution?
The generic name for Arformoterol Tartrate Inhalation Solution is Arformoterol Tartrate Inhalation Solution. There are no other listed brand versions of Arformoterol Tartrate Inhalation Solution.
What is the NDC code for Arformoterol Tartrate Inhalation Solution 15 ug/2mL?
The NDC (National Drug Code) for Arformoterol Tartrate Inhalation Solution 15 ug/2mL is 76204-026, listed by Ritedose Pharmaceuticals, LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)